Clinical Trial Update: The Safety and Efficacy of DCA for the Treatment of Brain Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports safety and efficacy data for dichloroacetate (DCA) in treating malignant gliomas, including glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Dichloroacetate (DCA) (dichloroacetate)

Snippet

Sponsor: University of Alberta | Conditions: Malignant Gliomas, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED